Rooms: 200/201/202 & 203/204/205

President’s Welcome/Opening Room: Chatham C

General Session 110: Keynote Address: Nurses as Agents of Change Room: Chatham C This keynote address will focus on the nurses ability to be change agents by looking at its past, present and future. Examples of historical moments in which nurses were instruments of change will be explored. Additionally, we will examine the effects of a weaning COVID pandemic on the healthcare system and the opportunities it presents for today's nurses to be drivers of change, promote autonomy and advocate for better health outcomes. Additionally, the nurse as an advocate will be explored. Learning Objectives: Explore and review the past history of nurse advocacy efforts from Florence Nightingale to present-day nurse advocates. Become aware of and discuss available resources that promote nurse advocacy efforts. Explore and discuss relevant issues of the nursing profession that participant may begin their advocacy efforts.

General Session 120: Skin Conditions in Skin of Color Room: Chatham C To provide clinicians with increased knowledge to differentiate skin color classification systems and treatment modalities for common skin disorders in patients with skin of color. For years, there have been gaps in education and training for clinicians to diagnose and treat dermatologic disorders in populations with skin of color. Many clinicians are trained on light complexions and undiagnosed or misdiagnosed on critical and time-sensitive treatment in peopled of skin of color. These disparities are important to address to avoid adverse effects and poor patient outcomes. The presenter will provide case studies for participants that aim to correct the disparities in diverse complexions of skin of color. Studies have revealed that there is a underrepresentation of dermatological conditions in patients with skin of color in textbooks, journals, and educational programs. It is crucial that clinicians should advance the field of dermatology but do so as a more inclusive and diverse specialty to provide the highest quality of care to all patients of color. Learning Objectives: Review skin disorders common among people with skin of color. Discuss differences of skin disorders in skin of color. Review treatment options for skin disorders in skin of color.

A Treatment Option for Patients with Uncontrolled Moderate-to-Severe Atopic Dermatitis Room: 200/201/202 Learn more about a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis. Sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.

General Session 140: Hidradenitis Suppurativa Room: Chatham C Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that is often recalcitrant to treatments. In recent years, there has been a tremendous push in the field of dermatology to make strides in HS research, and though HS is still difficult to treat, there are now more treatment options available that providers caring for HS patients should be aware of. Learning Objectives: Discuss early diagnosis and management of hidradenitis suppurativa. Identify challenges faced by HS patients and implement strategies to address them.

Room: Chatham AB

General Session 150: Pediatric Dermatology Emergencies Room: Chatham C This session will review dermatologic emergencies in pediatric patients. The goal is to identify rashes that require emergency care and distinguish them from those that can be managed as an outpatient. Learning Objectives: Identify dermatology emergencies in pediatric patients.

General Session 160: A Patient's Odyssey with Pemphigus Vulgaris
Room: Chatham C
A Patient's Journey will describe Daphne Smolka's experiences with a misdiagnosis and challenges to get a proper diagnosis. In addition, the process includes learning to accept and manage living with a rare autoimmune disease.
Learning Objectives: Understand the physical impact on Pemphigus and difficulty to diagnose. Understand the emotional/mental health impact of a rare autoimmune disease. Learn how nurses can reduce the burden of disease on overall well-being.